Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Am Soc Mass Spectrom ; 25(10): 1794-802, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25106707

ABSTRACT

For on-line monitoring of chemical reactions (batch or continuous flow), mass spectrometry (MS) can provide data to (1) determine the fate of starting materials and reagents, (2) confirm the presence of the desired product, (3) identify intermediates and impurities, (4) determine steady state conditions and point of completion, and (5) speed up process optimization. Recent developments in small footprint atmospheric pressure ionization portable mass spectrometers further enable this coupling, as the mass spectrometer can be easily positioned with the reaction system to be studied. A major issue for this combination is the transfer of a sample that is representative of the reaction and also compatible with the mass spectrometer. This is particularly challenging as high concentrations of reagents and products can be encountered in organic synthesis. The application of a portable mass spectrometer for on-line characterization of flow chemical synthesis has been evaluated by coupling a Microsaic 4000 MiD to the Future Chemistry Flow Start EVO chemistry system. Specifically, the Hofmann rearrangement has been studied using the on-line mass spectrometry approach. Sample transfer from the flow reactor is achieved using a mass rate attenuator (MRA) and a sampling make-up flow from a high pressure pump. This enables the appropriate sample dilution, transfer, and preparation for electrospray ionization. The capability of this approach to provide process understanding is described using an industrial pharmaceutical process that is currently under development. The effect of a number of key experimental parameters, such as the composition of the sampling make-up flow and the dilution factor on the mass spectrometry data, is also discussed.


Subject(s)
Drug Industry/instrumentation , Drug Industry/methods , Mass Spectrometry/instrumentation , Mass Spectrometry/methods , Drug Design , Equipment Design , Isocyanates/chemistry , Models, Molecular , Reproducibility of Results , Temperature
2.
J Mass Spectrom ; 46(11): 1168-74, 2011 Nov.
Article in English | MEDLINE | ID: mdl-22124989

ABSTRACT

A rapid, selective and sensitive method for quantification of latanoprost free acid in rabbit aqueous humor (AH) and ciliary body (CB) using reverse phase-high performance liquid chromatography coupled with electrospray ionization (ESI)-mass spectrometry/mass spectrometry has been developed and validated. Quantification in AH and CB was achieved by stable isotope dilution employing tetra-deuterated analog of latanoprost free acid, used as internal standard. Sample preparation was based on protein precipitation with methanol in AH, and on liquid extraction with a mixture of ethyl acetate and isopropanol 60:40 (v/v) in CB. Elution was achieved on an octylsilica (C8) column, using an isocratic elution method. Detection was performed on a triple quadrupole mass spectrometer, using ESI in positive ion selected reaction monitoring mode. Calibration curves were linear in the validated concentration ranges of 10-160 ng/mL in AH and 80-1280 ng/g in CB. The accuracy and precision values, obtained from three different sets of quality control samples, each analyzed in triplicate on three different days, were within the generally accepted criteria for analytical methods (< 15%). The limit of detection was 30.66 pg/mL in AH and 237.75 pg/g in CB. The assay proved to be accurate and precise when applied to the in vivo study of latanoprost free acid in rabbit AH and CB after single administration of an eye drops containing latanoprost.


Subject(s)
Aqueous Humor/chemistry , Chromatography, Liquid/methods , Ciliary Body/chemistry , Prostaglandins F, Synthetic/analysis , Spectrometry, Mass, Electrospray Ionization/methods , Animals , Drug Stability , Latanoprost , Least-Squares Analysis , Male , Rabbits , Reproducibility of Results , Sensitivity and Specificity , Tandem Mass Spectrometry/methods
3.
J Chromatogr B Analyt Technol Biomed Life Sci ; 878(9-10): 807-14, 2010 Mar 15.
Article in English | MEDLINE | ID: mdl-20153987

ABSTRACT

A rapid, sensitive and selective method for the simultaneous quantification of carteolol and dorzolamide in rabbit aqueous humor (AH) and ciliary body (CB) has been developed and validated using reversed phase-high performance liquid chromatography (RP-HPLC) with isocratic elution coupled with atmospheric pressure chemical ionization mass spectrometry/mass spectrometry (APCI-MS/MS). The analytes and nadolol (used as internal standard, IS) were purified from AH by protein precipitation. The sample preparation from CB was based on a two steps extraction procedure at different pH, utilizing a liquid-liquid extraction with a mixture of ethyl acetate, toluene and isopropanol 50:40:10 (v/v) at pH 8, followed by a second extraction with ethyl acetate at pH 11. The combined organic extracts were then back extracted into 0.1% aqueous trifluoroacetic acid (TFA). The accuracy and precision values, calculated from three different sets of quality control samples analyzed in sestuplicate on three different days, were within the generally accepted criteria for analytical methods (<15%). The assay proved to be accurate and precise when applied to the in vivo study of carteolol and dorzolamide in rabbit AH and CB after single administration of an eye drops containing both drugs.


Subject(s)
Antihypertensive Agents/analysis , Aqueous Humor/chemistry , Carteolol/analysis , Chromatography, High Pressure Liquid/methods , Ciliary Body/chemistry , Spectrometry, Mass, Electrospray Ionization/methods , Sulfonamides/analysis , Thiophenes/analysis , Animals , Antihypertensive Agents/therapeutic use , Carteolol/therapeutic use , Disease Models, Animal , Humans , Male , Ocular Hypertension/drug therapy , Rabbits , Sulfonamides/therapeutic use , Thiophenes/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...